ClinConnect ClinConnect Logo
Search / Trial NCT06379347

HOspitalized Patients and Clinical flUid Status, Assessment Using Point Of Care UltraSound

Launched by FLEVOZIEKENHUIS · Apr 18, 2024

Trial Information

Current as of August 21, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how effective a specific type of ultrasound, called point-of-care ultrasound (POCUS), is in assessing a patient's fluid status by looking at a blood vessel called the inferior vena cava (IVC). Doctors will use a portable ultrasound device at the bedside to check if patients have too much or too little fluid in their bodies. This study is important because while we know that IVC measurements can help in understanding fluid levels, most of the previous research has been done on very ill patients, and there’s less information about its use in regular hospital settings.

To participate in this trial, patients need to be over 18 years old and must have a medical reason to have an IVC ultrasound. Additionally, they should be staying in the hospital for at least 24 hours after the ultrasound is done. Patients who are on certain medications that support blood pressure or those needing special breathing assistance won’t be eligible. If you take part in the study, you can expect a qualified doctor to perform the ultrasound, which will help them make better decisions about your fluid management during your hospital stay.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient is over 18 years old.
  • Patient has a clinical indication for making a IVC ultrasound.
  • Patient is admitted until at least 24 hours after the first ultrasound.
  • Exclusion Criteria:
  • Patients who are using vasopressors at the time of the ultrasound.
  • Patients who require invasive or non-invasive (optiflow, CPAP, BPAP) ventilation.

About Flevoziekenhuis

Flevoziekenhuis is a prominent healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in the Netherlands, the hospital combines state-of-the-art facilities with a commitment to ethical research practices, ensuring patient safety and well-being. With a multidisciplinary team of experienced healthcare professionals, Flevoziekenhuis actively participates in various clinical studies across multiple therapeutic areas, aiming to contribute valuable insights to the medical community and enhance treatment options for patients. Their collaborative approach fosters partnerships with academic institutions and industry leaders, reinforcing their mission to drive progress in healthcare and deliver high-quality outcomes.

Locations

Almere, , Netherlands

Patients applied

0 patients applied

Trial Officials

Koen de Heer, MD PhD

Principal Investigator

Flevoziekenhuis

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported